2.0
5. Mai 2015
Aktueller Mitarbeiter, weniger als 1 Jahr
Deerfield, IL
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Company is splitting into two: Baxter & Baxalta. Baxalta is the high risk/high reward biotech focusing on oncology & hematology. Lots of potential upside from a growth perspective. New HQ just north of Deerfield
Kontras
Marketing division is way too top-heavy. Even in the new structure, I have 7 level of management to the CEO. Tons of chiefs and few worker bees leads to a great deal of extra work and managing up. Work load on both launch & in-line brands is extreme, and weekend work is the norm. Buyer beware: you may accelerate your career but at a personal price.
